ebook: Accelerate vaccine development
Posted: 13 May 2021 | Molecular Devices | No comments yet
Our comprehensive portfolio suite is designed to optimize your productivity to get safe and efficacious vaccines and therapeutics to market faster.
Immunology is now, more than anytime in recent history, one of the top fields of research. With antibody-drug conjugate and bispecific antibody products recently reaching the market, the use of mAbs will remain a key part of therapeutic development.
Learn more about:
- Automated screening & selection of high-expressing cell lines
- Novel antibody internalization and binding assays
- Easy expression assays
- Objective verification of monoclonalit
Related content from this organisation
- Plasmids: Tackling Supply Chain and Manufacturing Challenges
- Machine Learning and AI in Enhancing Image Analysis of 3D Samples
- Transform your drug discovery pipeline with 3D cellular models
- Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials
- Women in Stem with Vicky Marsh Durban
Related topics
Analytical Techniques, Antibodies, Assays, Biopharmaceuticals, Disease Research, Imaging, Immunology, Lab Automation, Microscopy, Proteomics, Stem Cells, Targets
Related organisations
Molecular Devices
